company background image
1061 logo

Essex Bio-Technology SEHK:1061 Stock Report

Last Price

HK$2.48

Market Cap

HK$1.4b

7D

0%

1Y

-27.1%

Updated

23 Jun, 2024

Data

Company Financials

Essex Bio-Technology Limited

SEHK:1061 Stock Report

Market Cap: HK$1.4b

1061 Stock Overview

An investment holding company, develops, manufactures, distributes, and sells bio-pharmaceutical products in the People’s Republic of China, Hong Kong, and internationally.

1061 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends4/6

Essex Bio-Technology Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Essex Bio-Technology
Historical stock prices
Current Share PriceHK$2.48
52 Week HighHK$3.60
52 Week LowHK$1.96
Beta0.26
11 Month Change-1.20%
3 Month Change5.08%
1 Year Change-27.06%
33 Year Change-68.33%
5 Year Change-63.80%
Change since IPO150.51%

Recent News & Updates

Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

May 06
Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

Recent updates

Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

May 06
Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Mar 21
Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Dec 07
Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 07
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Aug 25
Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Jun 22
Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

May 02
Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Mar 30
Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Jun 29
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Is Essex Bio-Technology (HKG:1061) A Risky Investment?

Mar 31
Is Essex Bio-Technology (HKG:1061) A Risky Investment?

If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

Mar 13
If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Feb 15
How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Jan 25
Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Jan 04
Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 13
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

Nov 23
Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

Shareholder Returns

1061HK BiotechsHK Market
7D0%-2.5%0.6%
1Y-27.1%-33.0%2.4%

Return vs Industry: 1061 exceeded the Hong Kong Biotechs industry which returned -33% over the past year.

Return vs Market: 1061 underperformed the Hong Kong Market which returned 2.4% over the past year.

Price Volatility

Is 1061's price volatile compared to industry and market?
1061 volatility
1061 Average Weekly Movement4.9%
Biotechs Industry Average Movement9.0%
Market Average Movement7.1%
10% most volatile stocks in HK Market15.1%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 1061 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1061's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19901,481Haizhou Fangwww.essexbio.com

Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells bio-pharmaceutical products in the People’s Republic of China, Hong Kong, and internationally. The company operates through Ophthalmology and Surgical segments. It researches and develops therapeutic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration.

Essex Bio-Technology Limited Fundamentals Summary

How do Essex Bio-Technology's earnings and revenue compare to its market cap?
1061 fundamental statistics
Market capHK$1.41b
Earnings (TTM)HK$275.26m
Revenue (TTM)HK$1.71b

5.1x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1061 income statement (TTM)
RevenueHK$1.71b
Cost of RevenueHK$167.26m
Gross ProfitHK$1.54b
Other ExpensesHK$1.26b
EarningsHK$275.26m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.49
Gross Margin90.20%
Net Profit Margin16.13%
Debt/Equity Ratio14.1%

How did 1061 perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

19%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.